MY128686A - Pharmaceutical composition containing selected lanthanum carbonate hydrates - Google Patents

Pharmaceutical composition containing selected lanthanum carbonate hydrates

Info

Publication number
MY128686A
MY128686A MYPI9704551A MY128686A MY 128686 A MY128686 A MY 128686A MY PI9704551 A MYPI9704551 A MY PI9704551A MY 128686 A MY128686 A MY 128686A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical composition
composition containing
lanthanum carbonate
containing selected
carbonate hydrates
Prior art date
Application number
Inventor
Barry Anthony Murrer
Nigel Anthony Powell
Original Assignee
Shire Int Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Int Licensing Bv filed Critical Shire Int Licensing Bv
Priority to MYPI9704551 priority Critical patent/MY128686A/en
Publication of MY128686A publication Critical patent/MY128686A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SELECTED LANTHANUM CARBONATE HYDRATES MAY BE ADMINISTERED INTO THE GASTROINTESTINAL TRACT, TO TREAT HYPERPHOSPHATAEMIA IN PATIENTS WITH RENAL FAILURE.
MYPI9704551 1997-09-30 1997-09-30 Pharmaceutical composition containing selected lanthanum carbonate hydrates MY128686A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9704551 MY128686A (en) 1997-09-30 1997-09-30 Pharmaceutical composition containing selected lanthanum carbonate hydrates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9704551 MY128686A (en) 1997-09-30 1997-09-30 Pharmaceutical composition containing selected lanthanum carbonate hydrates

Publications (1)

Publication Number Publication Date
MY128686A true MY128686A (en) 2007-02-28

Family

ID=47289684

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9704551 MY128686A (en) 1997-09-30 1997-09-30 Pharmaceutical composition containing selected lanthanum carbonate hydrates

Country Status (1)

Country Link
MY (1) MY128686A (en)

Similar Documents

Publication Publication Date Title
MX9707334A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates.
ZA973022B (en) New pharmaceutical composition with anaesthetic effect.
YU29901A (en) Utilisation of dialkylfumarates
MY124695A (en) Novel composition and use.
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
BRPI0309544B8 (en) storage stable oral pharmaceutical preparation comprising oxycodone and naloxone
EE04002B1 (en) Oral pharmaceutical dosage form containing a proton pump inhibitor and an antacid or alginate
ZA991077B (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia.
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HK1045113A1 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
WO2005034861A3 (en) A dried biotherapeutic composition, uses, and device and methods for administration thereof
MY128686A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates
IL156200A0 (en) Thymic epithelial progenitor cells and pharmaceutical compositions containing the same
PL315530A1 (en) Derivatives of 5-nitroimidazole in the form of microgranules
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
UA36221A (en) Method for treating chronic gastroduodenitis in children
AU9737198A (en) Pharmaceutical composition comprising 3,4-diarylchromans in low dose
AU4130100A (en) Pharmaceutical combination, containing a renin-angiotensin-system inhibitor, especially to be used in conjunction with hormone replacement therapy
ZA983242B (en) Novel piperaline compounds, processes for their preparation pharmacological compositions containing the same and their use in therapy.